comparemela.com

Latest Breaking News On - Shadow lake group - Page 2 : comparemela.com

Bioasis Provides Update on Business Operations

NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI) (the “Company” or “Bioasis”), a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage progr.

Actinium Pharmaceuticals, Inc and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and North Africa

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.